Survival Similar in Late, Early Diagnosed Neuroendocrine Neoplasms
Patients diagnosed with neuroendocrine neoplasms during later periods did not appear to experience better overall survival compared with patients diagnosed at an earlier time. In a study of 3,431 patients, older age at diagnosis, male sex, and stage 4 disease were linked with worse survival.
Related Posts
La inflamación cardiaca a largo plazo afecta a 1 de cada 8 pacientes hospitalizados con COVID
May 26, 2022
MIÉRCOLES, 25 de mayo de 2022 (HealthDay News) -- Un año tras ser hospitalizados...
COVID Has Robbed 5.2 Million Children Worldwide of Parent, Caregiver
February 25, 2022
FRIDAY, Feb. 25, 2022 (HealthDay News) -- At least 5.2 million children...
FDA Says Retail Pharmacies Can Now Offer Abortion Pills
January 4, 2023
WEDNESDAY, Jan. 4, 2023 (HealthDay News) – The U.S. Food and Drug Administration...
Biden Moves to Lower Health Care Costs, Limit Insurance Junk Fees
July 10, 2023
MONDAY, July 10, 2023 (HealthDay News) -- When they need health care, Americans...
